首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2015篇
  免费   118篇
  国内免费   6篇
耳鼻咽喉   23篇
儿科学   89篇
妇产科学   33篇
基础医学   231篇
口腔科学   60篇
临床医学   180篇
内科学   426篇
皮肤病学   91篇
神经病学   97篇
特种医学   444篇
外科学   236篇
综合类   53篇
预防医学   34篇
眼科学   20篇
药学   66篇
  1篇
中国医学   1篇
肿瘤学   54篇
  2023年   12篇
  2022年   13篇
  2021年   18篇
  2020年   17篇
  2019年   27篇
  2018年   24篇
  2017年   32篇
  2016年   38篇
  2015年   35篇
  2014年   54篇
  2013年   58篇
  2012年   43篇
  2011年   67篇
  2010年   80篇
  2009年   87篇
  2008年   66篇
  2007年   65篇
  2006年   59篇
  2005年   51篇
  2004年   46篇
  2003年   39篇
  2002年   29篇
  2001年   43篇
  2000年   21篇
  1999年   33篇
  1998年   83篇
  1997年   83篇
  1996年   82篇
  1995年   69篇
  1994年   47篇
  1993年   59篇
  1992年   10篇
  1991年   18篇
  1990年   30篇
  1989年   61篇
  1988年   47篇
  1987年   51篇
  1986年   58篇
  1985年   73篇
  1984年   38篇
  1983年   32篇
  1982年   30篇
  1981年   34篇
  1980年   39篇
  1979年   11篇
  1978年   22篇
  1977年   24篇
  1976年   25篇
  1975年   25篇
  1974年   9篇
排序方式: 共有2139条查询结果,搜索用时 15 毫秒
81.
To validate the level of olfactory performance of children, we tested 825 volunteers, aged 4–17 years, with an abbreviated form of our pediatric odorant identification task. The test consisted of sniffing and identifying five odorants (baby powder, bubble gum, candy cane, licorice and peach). Mean olfactory scores increased as a function of age, reaching a plateau of about 94–95% correct at 8 years of age. In general, girls out–performed boys. Physicians require a test instrument such as the one we have devised to allow them to diagnose olfactory dysfunction in children. The present task is particularly applicable in screening large numbers of children in clinics or schools because it can be administered easily and rapidly. Adult subjects with olfactory dysfunction also performed poorly on this odorant identification task designed for children. Therefore, we expect that our odorant identification task will also detect children with severe olfactory dysfunction.  相似文献   
82.
83.
84.
Liver transplantation (OLT) for end-stage chronic hepatitis-B-virus (HBV) infection is frequently complicated by HBV recurrence. In the present study we investigated whether human leucocyte antigen (HLA)-matching influences the outcome after OLT. In a retrospective analysis we reviewed 84 recipients of liver transplants for end-stage HBV-cirrhosis and complete HLA-typing for outcome after OLT. Follow-up ranges from 1 to 110 months (median = 55.6 months). Immunosuppression consisted of Cyclosporin A (CsA)-based quadruple induction therapy or Tacrolimus-based induction protocols. Immunoprophylaxis with hepatitis B immunoglobulin was started at OLT and continued long-term. Actuarial 1- and 5-yr graft survival figures were 90.5 and 80.4%, respectively. Hepatitis-B recurrence was responsible for 15 of 20 (75%) graft failures. We observed a significantly improved graft survival in patients with more HLA-A, -B compatibilities (p = 0.02), whereas the degree of HLA-DR compatibilities did not influence the outcome. The occurrence of HBV-reinfection was significantly lower in HLA-A, -B matched grafts (p < 0.05). Additionally, graft survival was prolonged in patients with HBV-reinfection and 1 or 2 HLA-B compatibilities when compared with patients with HBV-reinfection and a complete HLA-B mismatch (p = 0.02). In conclusion, this retrospective analysis shows that more HLA-A, -B compatibilities seems to be associated with an improved graft survival in patients after OLT for end-stage HBV infection.  相似文献   
85.
Solid lipid nanoparticles (SLN) were developed at the beginning of the 1990 s as an alternative carrier system to emulsions, liposomes and polymeric nanoparticles. The paper reviews advantages-also potential limitations-of SLN for the use in topical cosmetic and pharmaceutical formulations. Features discussed include stabilisation of incorporated compounds, controlled release, occlusivity, film formation on skin including in vivo effects on the skin. As a novel type of lipid nanoparticles with solid matrix, the nanostructured lipid carriers (NLC) are presented, the structural specialties described and improvements discussed, for example, increase in loading capacity, physical and chemical long-term stability, triggered release and potentially supersaturated topical formulations. For both SLN and NLC, the technologies to produce the final topical formulation are described, especially the production of highly concentrated lipid nanoparticle dispersions >30-80% lipid content. Production issues also include clinical batch production, large scale production and regulatory aspects (e. g. status of excipients or proof of physical stability).  相似文献   
86.
87.
88.
89.
OBJECT: The goals of this study were to define the incidence of seizures in children with low-grade tumors, study seizure outcome after lesionectomy in these children, and identify risk factors for poor seizure outcome, METHODS: The authors performed a retrospective chart review of children who harbored low-grade brain tumors, experienced seizures, and were treated in a single institution, Statistical analyses included step-wise as well as single-variable binary logistic regression analyses.  相似文献   
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号